The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the agenda: the hepatitis B vaccine, the overall childhood vaccine schedule and specific vaccine ingredients.

Health Secretary Robert F. Kennedy Jr. and his allies are trading their chisels for a sledgehammer when it comes to vaccine policy, delighting the "Make America Healthy Again" faithful. Why it matters: Trump health officials and like-minded outside advisers are taking the most concrete steps yet to enshrine Kennedy's criticism of vaccines as official government policy,

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA formally recommended pausing their use, and they were later pulled from the market.

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend it.

Comments by President Trump, Health Secretary Robert F. Kennedy Jr. and some panelists suggest the committee is likely to delay hepatitis B shots and discuss revising the use of other vaccines.

A dozen former leaders of the U.S. Food and Drug Administration (FDA) on Wednesday slammed the Trump administration over its changes to vaccine policy, calling these changes a threat to public

An advisory committee overseen by Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine advisory board will meet Thursday to discuss the medical guidance of the hepatitis B vaccine, which is currently given at birth.

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that success.